Cite
HARVARD Citation
Holkova, B. et al. (2017). A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leukemia & lymphoma. 58 (6), pp. 1349-1357. [Online].